Related Experiment Video
Updated: May 16, 2026
10:29
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Nucleoside/nucleotide analogue polymerase inhibitors in development
1Division of Gastroenterology/Hepatology, Liver Disease Center, Scripps Clinic, La Jolla, CA 92067, USA. pockros.paul@scrippshealth.org
Clinics in Liver Disease
|November 27, 2012
Summary
Nucleoside/nucleotide analogue polymerase inhibitors (NPIs) like sofosbuvir are effective against viral RNA generation. Adding ribavirin to NPI regimens reduces viral breakthrough in patients.
Area of Science:
- Virology
- Pharmacology
- Hepatology
Background:
- Nucleoside/nucleotide analogue polymerase inhibitors (NPIs) target the NS5B active site, inhibiting viral RNA synthesis.
- NPIs offer a high genetic barrier to resistance and are effective across all viral genotypes.
- Sofosbuvir (GS-7977) is a key NPI demonstrating potent antiviral activity and suitability for combination therapies.
Purpose of the Study:
- To evaluate the role of NPIs, specifically sofosbuvir, as backbone agents in all-oral antiviral treatment regimens.
- To assess the efficacy of combination therapies involving sofosbuvir and the impact of ribavirin on viral breakthrough.
Main Methods:
- Review of clinical trial data and interim analyses concerning NPIs and combination antiviral therapies.
- Analysis of viral breakthrough rates in patients treated with direct-acting antiviral agents, with and without ribavirin.
Main Results:
- Sofosbuvir exhibits high antiviral activity and a high genetic barrier to resistance, positioning it as an optimal candidate for combination therapy.
- Interim analyses show that all-oral regimens with two direct-acting antiviral agents can lead to viral breakthrough.
- The addition of ribavirin significantly reduces viral breakthrough compared to regimens without it, excluding pegylated interferon α.
Conclusions:
- NPIs, exemplified by sofosbuvir, are crucial for developing effective all-oral antiviral treatments.
- Combination therapy including ribavirin is essential for minimizing viral breakthrough and enhancing treatment efficacy.
- Further clinical trials are investigating the full potential of sofosbuvir-based all-oral regimens.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:28Biosynthesis of Nucleic Acids
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:10Translesion DNA Polymerases
Translesion (TLS) polymerases rescue stalled DNA polymerases at sites of damaged bases by replacing the replicative polymerase and installing a nucleotide across the damaged site. Doing so, TLS allows additional time for the cell to repair the damage before resuming regular DNA replication.
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...